Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?

We evaluated NK cell subsets and functions in previously immunodeficient HIV patients responding to ART. Cytokine receptor mRNA was quantitated in purified CD56+ cells. Data were correlated with CD4+ T-cell counts and IFN? responses to CMV. NK cell IFN? responses to K562 cells and proportions of CD5...

Full description

Bibliographic Details
Main Authors: Tan, D., Fernandez, S., French, M., Price, Patricia
Format: Journal Article
Published: Academic Press 2009
Online Access:http://hdl.handle.net/20.500.11937/20399
_version_ 1848750294664478720
author Tan, D.
Fernandez, S.
French, M.
Price, Patricia
author_facet Tan, D.
Fernandez, S.
French, M.
Price, Patricia
author_sort Tan, D.
building Curtin Institutional Repository
collection Online Access
description We evaluated NK cell subsets and functions in previously immunodeficient HIV patients responding to ART. Cytokine receptor mRNA was quantitated in purified CD56+ cells. Data were correlated with CD4+ T-cell counts and IFN? responses to CMV. NK cell IFN? responses to K562 cells and proportions of CD56lo NK cells were correlated in patients (p < 0.001) and both were lower than in controls (p < 0.001 and p = 0.008, respectively), so all patients had poor NK cell function. Proportions of CD56hi NK cells correlated inversely with current CD4+ T-cell counts (p = 0.006) and perforin expression in CD56hi NK cells was higher in patients than controls (p < 0.05). Hence increased proportions and cytolytic function of CD56hi NK cells may partially compensate for CD4+ T-cell deficiency. NK cell IFN? responses correlated inversely with expression of IL-10 and IL-12 receptor mRNA. Expression of these transcripts is reduced by exposure to the cytokines, which may reflect immune activation in immunodeficient patients. © 2009 Elsevier Inc. All rights reserved.
first_indexed 2025-11-14T07:34:33Z
format Journal Article
id curtin-20.500.11937-20399
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:34:33Z
publishDate 2009
publisher Academic Press
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-203992017-09-13T13:49:37Z Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy? Tan, D. Fernandez, S. French, M. Price, Patricia We evaluated NK cell subsets and functions in previously immunodeficient HIV patients responding to ART. Cytokine receptor mRNA was quantitated in purified CD56+ cells. Data were correlated with CD4+ T-cell counts and IFN? responses to CMV. NK cell IFN? responses to K562 cells and proportions of CD56lo NK cells were correlated in patients (p < 0.001) and both were lower than in controls (p < 0.001 and p = 0.008, respectively), so all patients had poor NK cell function. Proportions of CD56hi NK cells correlated inversely with current CD4+ T-cell counts (p = 0.006) and perforin expression in CD56hi NK cells was higher in patients than controls (p < 0.05). Hence increased proportions and cytolytic function of CD56hi NK cells may partially compensate for CD4+ T-cell deficiency. NK cell IFN? responses correlated inversely with expression of IL-10 and IL-12 receptor mRNA. Expression of these transcripts is reduced by exposure to the cytokines, which may reflect immune activation in immunodeficient patients. © 2009 Elsevier Inc. All rights reserved. 2009 Journal Article http://hdl.handle.net/20.500.11937/20399 10.1016/j.clim.2009.03.518 Academic Press restricted
spellingShingle Tan, D.
Fernandez, S.
French, M.
Price, Patricia
Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
title Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
title_full Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
title_fullStr Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
title_full_unstemmed Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
title_short Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
title_sort could natural killer cells compensate for impaired cd4+ t-cell responses to cmv in hiv patients responding to antiretroviral therapy?
url http://hdl.handle.net/20.500.11937/20399